A registered nurse pulls up to a downtown hotel at 9:30 a.m., wheels a tackle box of saline bags and B-complex vials into a bachelorette suite, and walks out 45 minutes later with a $389 charge run on a tablet. By lunch she has visited two more clients, a Pilates instructor with calf cramps and a Wall Street consultant battling jet lag. Her van has effectively been a $1,200-revenue rolling clinic before noon.
That van is the headline of an industry that has gone from novelty to mainstream in less than a decade. The global mobile IV hydration services market is on track to crack the $15 billion mark by 2026, with average gross margins running 30 to 60 percent and startup costs anywhere between $5,000 and $150,000 depending on whether you are a solo RN with a leased SUV or a multi-van operator with a brick-and-mortar dispatch hub. The business is seductive: high ticket, repeat purchasers, zero insurance billing, and a customer base that genuinely enjoys the service.
It is also one of the most legally booby-trapped small businesses in healthcare. Get the corporate structure wrong and you have violated the corporate practice of medicine doctrine. Get the pharmacy sourcing wrong and you have violated federal compounding law. Get the medical director contract wrong and you are exposed under the Anti-Kickback Statute. And get the bookkeeping wrong and you cannot even tell whether your margins survived the regulatory cost of doing business right.
This guide walks through the bookkeeping playbook that mobile IV operators need to keep all of those plates spinning.
The Corporate Structure Drives Every Journal Entry
Before you record a single transaction, you need to know who owns what. In roughly thirty states, the Corporate Practice of Medicine (CPOM) doctrine prohibits non-physicians from owning entities that practice medicine. Because IV therapy involves the prescription and administration of drugs, courts and state attorneys general overwhelmingly treat it as the practice of medicine, even when it is delivered by a registered nurse rather than a physician.
The compliant structure is the Friendly Professional Corporation / Management Services Organization (PC/MSO) model:
- A Professional Corporation (PC) or Professional LLC (PLLC) is owned by a licensed physician. The PC holds the medical license, employs or contracts the clinical staff (the medical director, the RNs, the nurse practitioners), and bills patients for medical services.
- A Management Services Organization (MSO) is owned by the non-physician entrepreneur or investor. The MSO owns the vans, the equipment, the brand, the booking app, and the dispatch operation. It provides administrative, marketing, scheduling, and billing services to the PC under a written Management Services Agreement (MSA).
The MSA is the most important contract in the business. It governs the management fee that the PC pays the MSO, and that fee is the only legitimate way an entrepreneur can extract cash from a Friendly-PC structure. Best practice is to set the fee using either a fixed monthly amount or a cost-plus-reasonable-markup formula, both documented with a Fair Market Value (FMV) opinion at the time the contract is signed and re-papered annually.
A flat percentage-of-revenue fee is the structure regulators love to litigate. A few states permit it; most are skeptical because it puts the MSO economically in control of medical decisions. Whatever you choose, document it in writing, keep an FMV file, and book the inter-company transfers on the same date each month so the audit trail tells one consistent story.
Your bookkeeping system needs to reflect two distinct entities with two distinct ledgers. The MSO and the PC each need their own bank accounts, their own QuickBooks file (or Beancount ledger), and their own tax return. Consolidate only at year-end for the owner's personal return when both are flow-through. Commingling funds is the fastest way to lose the corporate veil and the CPOM defense.
Recognizing Revenue Under ASC 606
Mobile IV businesses have surprisingly complex revenue streams for what looks like a simple cash-and-carry service. You need to separate them on the books because each one behaves differently under ASC 606, the revenue recognition standard.
Per-Visit Treatment Revenue
The most common transaction is a single visit at a single price. A "Myers' Cocktail" for $250 delivered to a hotel room is recognized as revenue on the date of service when the performance obligation (administering the infusion) is satisfied. Use service-date recognition, not the date the charge cleared, and book it gross of credit-card processing fees.
Add-On Pushes and Boosters
Many mobile IV companies sell add-ons on top of a base infusion: a B-12 push for $35, glutathione for $50, NAD+ for $300. ASC 606 treats each of these as a distinct performance obligation because each is separately priced and separately administered. Your point-of-sale software should itemize them, and your general ledger should map each to its own revenue account so that gross margin can be measured per SKU.
Concierge Travel Fees
The $50 or $75 travel charge that some operators add for visits outside a base ZIP code is a separate performance obligation from the infusion itself. It compensates the company for transportation, not medical service. Booking it to a distinct "Concierge Travel Revenue" account lets you track whether your dispatch radius is profitable and whether you need to raise the travel charge in a high-fuel month.
Membership Subscriptions
The fastest-growing revenue stream in the industry is the monthly membership: a customer pays $99 to $199 a month in exchange for one included infusion plus member pricing on add-ons. This is the most common ASC 606 trap in the industry.
The right treatment: receive the cash, debit Cash, credit Deferred Revenue (Liability). As the included service is delivered each month (or as the month elapses if it is a use-it-or-lose-it model), recognize the revenue. If the membership rolls forward unused services, you have a contract-liability question that requires a breakage analysis — historical data on how often members redeem the included service.
Operators who simply book the $149 as revenue when the credit card runs end up overstating revenue in January and February and missing the deferred-revenue tail in March, April, and May. The income statement looks great until you ask why margins fell off a cliff in Q2.
Prepaid Treatment Packages
A "ten-pack" of Myers' Cocktails sold for $2,000 ($200 each, down from a $250 single-visit price) is a contract with a customer for ten future performance obligations. Book the full $2,000 to deferred revenue on sale; release $200 to revenue each time a pack is redeemed. Set an internal policy on breakage — if packs expire after twelve months, build a historical breakage rate (say, 8 percent) into your monthly revenue release, but document the methodology.
Pharmacy COGS Through 503A and 503B Compounders
The single largest variable cost in a mobile IV business is the pharmacy inventory: the saline bags, the vitamins, the amino acids, the NAD+, the glutathione, the lidocaine. Where you buy these matters legally, and how you account for them matters for gross margin.
Understanding 503A vs. 503B
Section 503A pharmacies compound on a per-prescription, per-patient basis. They cannot ship "office-use" stock to clinics in bulk. Section 503B "outsourcing facilities" are registered with the FDA, operate under cGMP-equivalent standards, and may sell to clinics in batches without a patient-specific prescription. Most mobile IV companies should be sourcing their bulk inventory from 503B outsourcing facilities — PCAB-accredited operations such as the ones that supply national mobile chains — and using 503A pharmacies only for true patient-specific compounds.
This distinction has accounting consequences. 503B inventory is typically purchased on net-30 terms in batch quantities with multi-month shelf life, while 503A inventory is purchased on demand. Set up two separate inventory sub-accounts in your chart so you can see at a glance whether your buying mix matches your regulatory story.
Booking COGS Correctly
Mobile IV gross margin is typically reported in the 70 to 90 percent range, but the way you compute it varies wildly across operators. To compare yourself to the industry, you need a disciplined definition. Pharmacy COGS should include:
- The cost of the IV bag itself (saline, lactated Ringer's, dextrose)
- The compounded additives (vitamins, NAD+, glutathione, amino acids)
- The IV tubing set, catheter, alcohol prep, gauze, tape, sharps container disposal
- Patient-facing consumables (gloves, electrolyte recovery drinks if included)
Pharmacy COGS should not include:
- The RN's clinical labor (that is Salaries & Wages or 1099 Contractor expense)
- The travel time and mileage (that is Transportation expense or Mileage allocation)
- The medical director stipend (that is a fixed Medical Director expense in the PC)
Tracking inventory at the bag-level via your point-of-sale system and reconciling monthly against pharmacy invoices catches both shrinkage and pricing creep — and pricing creep is real, because 503B facilities have been raising prices steadily as demand grows.
Office-Use Compounding Compliance
This is worth flagging twice because it is the single most common compliance error: a clinic owner buys "office stock" of compounded glutathione from a 503A pharmacy without a patient-specific prescription, and now both the pharmacy and the clinic have a federal violation. Your accounts payable system should require that invoices from any 503A vendor either reference patient names (rare) or be flagged for refusal. Make the bookkeeper part of the compliance perimeter.
Medical Director Stipends and Anti-Kickback Risk
The Friendly-PC model relies on a physician who serves as the medical director: signing standing orders, reviewing protocols, conducting QA on cases, and being available for clinical questions. Most mobile IV companies do not employ this physician full-time; they pay a monthly stipend (anywhere from $1,500 to $10,000 depending on volume and state).
That stipend is the single line item the Anti-Kickback Statute (AKS) and the Stark Law look at hardest. The AKS criminalizes payments intended to induce referrals for items reimbursable by a federal healthcare program. Stark prohibits self-referral by physicians with financial relationships to designated health service entities.
For mobile IV companies that take only cash payment, neither statute applies to your patient revenue directly because there is no federal reimbursement involved. However, two scenarios drag you in:
- The medical director also refers patients to the clinic. Suppose your medical director is a local concierge physician who also bills Medicare for office visits. If he refers his Medicare patients to your IV business and you pay him a stipend, you have an AKS exposure even though your revenue is private-pay, because the stream of referrals is the issue, not the payor mix on the IV side.
- The medical director is paid above Fair Market Value for the actual services rendered. A $10,000-per-month stipend for a physician who signs ten standing orders per quarter is almost certainly above FMV and looks to a prosecutor like disguised remuneration.
Bookkeeping protections:
- Maintain a monthly written attestation from the medical director documenting hours spent on chart review, protocol updates, and QA calls. Attach it to the invoice.
- Pay the stipend out of the PC, not the MSO. This is non-negotiable; an MSO paying a clinical physician for clinical services collapses the corporate firewall.
- Book the stipend to a clearly labeled "Medical Director — Clinical Oversight" expense account. Do not bury it in "Professional Fees."
- Keep the FMV opinion in the audit folder for the same year you took the deduction.
RN Classification: W-2 vs. 1099 Under State ABC Tests
Few mobile IV companies want full-time W-2 RNs sitting on the bench waiting for the next booking. The financial logic argues for 1099 contractor nurses paid per visit. The legal reality in California (Dynamex/AB5), New Jersey, Massachusetts, and several other ABC-test states is that an RN who works your booking app, wears your branded scrubs, follows your standing orders, and uses your supplies almost always fails the "B" prong of the ABC test ("worker performs work outside the usual course of the hiring entity's business").
When she fails the test, she is a W-2 employee. The cost differential is meaningful: you now owe FICA, FUTA, SUTA, workers' compensation, and unemployment insurance — roughly 12 to 15 percent on top of cash wages. Build that into your pricing model from day one.
For bookkeeping, set up parallel payroll structures:
- W-2 RN compensation: gross wages, employer FICA, employer Medicare, FUTA, SUTA, workers' comp accrual, health insurance, and any 401(k) match. Each component is its own expense account.
- 1099 RN compensation: gross contractor payments, tracked by contractor for Form 1099-NEC reporting at year-end. Issue a 1099-NEC to any contractor paid $600 or more.
Misclassification penalties are not just IRS exposure. State labor departments can impose back-wage liability, unpaid overtime, missed-break premiums, and PAGA penalties in California. The 1099 model also dilutes your CPOM defense, because the PC is supposed to be the entity engaging clinical workers.
Capital Equipment: Section 179 and Vehicle Depreciation
A mobile IV operator buys equipment that depreciates on three different schedules:
- The van or SUV: Section 280F luxury auto limits apply if the vehicle's gross vehicle weight rating is under 6,000 pounds. A Sprinter-class van over 6,000 pounds GVWR qualifies for Section 179 expensing up to $1,160,000 in 2026 (subject to phase-out above $2,890,000 in equipment placed in service). A Ford Transit or Mercedes Sprinter that becomes your "treatment unit" is a strong Section 179 candidate.
- Clinical equipment: IV poles, refrigeration units (for medications requiring cold chain), point-of-care lab analyzers (if you offer vitamin level testing), portable patient chairs, and biometric monitors are five- or seven-year property under MACRS but qualify for Section 179 in the year placed in service.
- Computers and software: Booking app subscriptions are an immediately deductible operating expense. A custom-built dispatch platform that you capitalize as internal-use software is subject to ASC 350-40 with a three- to five-year amortization.
The De Minimis Safe Harbor election ($2,500 per invoice line without an applicable financial statement, $5,000 with) lets you expense the disposable-feeling capital items immediately. Make the annual election with your tax return and document it in your accounting manual.
Insurance: The Bookkeeping Line That Hides Your Real Risk
Insurance is the line item that mobile IV operators most often under-fund. The right stack:
- Professional Liability / Medical Malpractice: claims-made coverage on the PC at limits appropriate for IV procedures. Even a properly placed IV can result in extravasation, nerve damage, or allergic reaction.
- General Liability: on the MSO for slip-and-fall, property damage, and non-clinical incidents.
- Commercial Auto: on the van; personal auto policies almost universally exclude commercial use.
- Workers' Compensation: on every W-2 RN, in every state where they work.
- Cyber Liability / HIPAA Breach: chart records on a tablet that gets stolen at a hotel is the canonical breach. A $1 million sub-limit is a sensible starting point.
- Excess / Umbrella: $1 million to $5 million sitting on top of the GL and Auto layers.
Track premiums as prepaid insurance when paid annually, then amortize monthly to insurance expense over the policy period. Booking the full premium as expense in the month paid creates a 12-month margin distortion you do not want.
Reserve for the self-insured retention (SIR) on the malpractice tower as a contingent liability disclosed in the notes; do not accrue it on the balance sheet unless a specific claim has been reported.
The KPIs That Actually Matter
Industry benchmarks for mobile IV companies are starting to settle around a few core metrics. Track these monthly:
- Average Revenue Per Treatment (ARPT): total revenue divided by total treatments. The industry benchmark for mobile health clinics is around $94, but pure IV-focused businesses with NAD+ and concierge premiums often run $200 to $350. Watch the trend; if ARPT is falling, your add-on attach rate is probably weakening.
- RN Capacity Utilization: treatments per RN per month divided by maximum capacity. Industry target is 65 to 75 percent in the first year, climbing to 85 percent for mature operators. Below 50 percent means you are paying for too many on-call nurses.
- Gross Margin on Treatments: revenue less pharmacy COGS less direct clinical labor. Stay above 60 percent for mobile IV; above 75 percent for high-end concierge IV. The 30 to 60 percent industry-wide figure includes operators carrying heavy vehicle and brand-marketing burden — your treatment-level gross margin should be higher than that blended number.
- Repeat Patient Rate / Membership Conversion: percentage of first-time visitors who book a second visit within 90 days, and the percentage who convert to a membership. Mature operators see 30 to 45 percent repeat rates and 15 to 25 percent membership conversion on first visit. The economics of the business break if repeat is below 25 percent — you are running an expensive customer acquisition treadmill.
- Contribution Margin Per Visit: revenue per visit minus pharmacy COGS, RN clinical labor, and direct travel cost (mileage at IRS rate). This number tells you whether the marginal visit is worth taking; if it dips below $50 per visit in a slow ZIP code, you should redraw your service radius.
- Cost Per Acquired Customer (CAC): marketing spend divided by new customers. Mobile IV CAC commonly runs $40 to $120 depending on channel. Combined with your repeat rate and lifetime gross margin, this drives the LTV/CAC ratio that determines whether your marketing budget is actually buying growth.
A monthly dashboard that pulls these from the books — not the booking app, the books — is the discipline that distinguishes the mobile IV operator who survives from the one whose tax return tells a depressing story about a great-looking Instagram brand.
Common Bookkeeping Mistakes That Cost Operators Six Figures
A few recurring patterns I see in the industry:
- MSO and PC commingling. The owner pays the medical director from the MSO account because "it's faster." Once, sure. Habitually, you have blown the corporate firewall.
- Booking memberships as current revenue. A great Q1 turns into a confusing Q2 when the prepaid services finally have to be honored at a marginal cost.
- Treating 503A bulk purchases as compliant. The pharmacy goes along with it because they want the business; the compliance lawyer finds it the day a state pharmacy board audit lands.
- No FMV file on the medical director. When the OIG asks how you set the stipend, "we picked a number that felt right" is not a defense.
- Misclassifying every RN as 1099. Texas may tolerate it; California will assess back wages, payroll taxes, and PAGA penalties in a single audit.
- No tracking of pharmacy shrinkage. Vials of glutathione walk; bags of saline get tossed past expiry. Without a monthly count, you do not know your real COGS until inventory writedowns hit at year-end.
Keep Your Books Clean from Day One
Mobile IV hydration is one of the few cash-pay healthcare businesses with healthy gross margins and a national runway for growth — but it is also a business where one bad audit, one CPOM complaint, or one misclassified contractor can erase a year of profit. The defense is boring: a chart of accounts that mirrors your corporate structure, a revenue recognition policy that respects ASC 606, a pharmacy procurement workflow that distinguishes 503A from 503B, and a monthly dashboard that ties to the books rather than the booking app.
If your books cannot tell a clean story about the MSO, the PC, the medical director stipend, the deferred-revenue stack, and the per-treatment margin, they will not be able to tell a clean story to a regulator either. Build the discipline before the audit notice arrives.
Keep Your Financial Records Clean and Audit-Ready
As you scale a mobile IV hydration business — with separate entities, deferred memberships, multi-vendor pharmacy COGS, and a medical director stipend that must survive a Fair Market Value test — maintaining clear, version-controlled financial records is essential. Beancount.io provides plain-text accounting that gives you complete transparency and control over your financial data, with the kind of granular account structure that makes a Friendly-PC/MSO setup auditable rather than mystifying. Get started for free and see why developers and finance professionals trust plain-text accounting for businesses where the books cannot afford to be a black box.